These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7073530)

  • 21. View from the Nation's Capital. New drug application (NDA) and investigational new drug (IND) regulations.
    Romansky MA
    J Clin Psychopharmacol; 1983 Dec; 3(6):380-3. PubMed ID: 6680409
    [No Abstract]   [Full Text] [Related]  

  • 22. Medical devices; exemption from premarket notification requirements; class I devices; technical amendment. Final rule; technical amendment.
    Food and Drug Administration. HHS
    Fed Regist; 2001 Jul; 66(143):38786-819. PubMed ID: 11725800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Food and Drug Administration's regulation of dental products.
    Pinco RG; Rubin PD
    J Clin Dent; 1995; 6(3):165-9. PubMed ID: 8615957
    [No Abstract]   [Full Text] [Related]  

  • 24. Hiding behind agency discretion: the Food and Drug Administration's personal use drug importation policy.
    Reichertz PS; Friend MS
    Cornell J Law Public Policy; 2000; 9():493-521. PubMed ID: 11067734
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of surgical volume and the early experience with lumbar total disc replacement as part of the investigational device exemption study of the Charité Artificial Disc.
    Regan JJ; McAfee PC; Blumenthal SL; Guyer RD; Geisler FH; Garcia R; Maxwell JH
    Spine (Phila Pa 1976); 2006 Sep; 31(19):2270-6. PubMed ID: 16946666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medicare and Medicaid programs; quarterly listing of program issuances; fourth quarter 1996--HCFA. Notice.
    Fed Regist; 1997 May; 62(91):25957-9. PubMed ID: 10167529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The food and Drug Administration's view of investigational drugs.
    MEYERS EL
    SD J Med Pharm; 1963 Jul; 16():40-6. PubMed ID: 13935340
    [No Abstract]   [Full Text] [Related]  

  • 28. Court is asked to invalidate the Food and Drug Administration's (FDA's) "pediatric rule".
    Maloney DM
    Hum Res Rep; 2002 Dec; 17(12):8. PubMed ID: 12731500
    [No Abstract]   [Full Text] [Related]  

  • 29. Economic cost for implementation of the U.S. Food and Drug Administration's Code of Federal Regulations Title 21, Part 1271 in an egg donor program.
    Baker VL; Gvakharia MO; Rone HM; Manalad JR; Adamson GD
    Fertil Steril; 2008 Sep; 90(3):537-45. PubMed ID: 17953961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanded access to investigational drugs for treatment use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Aug; 74(155):40900-45. PubMed ID: 19691173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigational new drug application; exception from informed consent; technical amendment--FDA. Final rule.
    Fed Regist; 1997 Jun; 62(115):32479. PubMed ID: 10169828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artificial organs: learning to live with risk.
    Galletti PM
    Technol Rev; 1988; 91(8):34-40. PubMed ID: 10303053
    [No Abstract]   [Full Text] [Related]  

  • 33. Human subject protection; foreign clinical studies not conducted under an investigational new drug application. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Apr; 73(82):22800-16. PubMed ID: 18567164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanics of the Food and Drug Administration's Form 1571: investigational new drug application.
    Novack G
    Retina; 2005 Dec; 25(8 Suppl):S96-S97. PubMed ID: 16374362
    [No Abstract]   [Full Text] [Related]  

  • 35. Artificial organs of the future.
    Olsen DB
    ASAIO J; 1992; 38(3):M134-8. PubMed ID: 1457832
    [No Abstract]   [Full Text] [Related]  

  • 36. Conforming regulations regarding removal of section 507 of the Federal Food, Drug, and Cosmetic Act; confirmation of effective date. Food and Drug Administration, HHS. Direct final rule; confirmation of effective date.
    Fed Regist; 1999 May; 64(94):26657. PubMed ID: 10558515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of good manufacturing practice regulations to investigational biologic products.
    Goebel PW
    J Parenter Drug Assoc; 1980; 34(5):348-51. PubMed ID: 6905865
    [No Abstract]   [Full Text] [Related]  

  • 38. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anchors away: the Food and Drug Administration's use of disgorgement abandons legal moorings.
    Vodra WW; Levine AN
    Food Drug Law J; 2004; 59(1):1-30. PubMed ID: 15190923
    [No Abstract]   [Full Text] [Related]  

  • 40. Medical device reporting: the US final rule.
    Donawa ME
    Med Device Technol; 1996 Mar; 7(2):14-6, 18, 20-1. PubMed ID: 10159867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.